0 items USD 0.00Search
Your search for "delveinsight oligodendroglioma pipeline insight 2018" gave back 1288541 results.
Receptor Tyrosine Protein Kinase ERBB 4 - Pipeline Review, H2 2019 Summary According to the recently published report 'Receptor Tyrosine Protein...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Pipeline Review, H2 2018 Summary Cellular Tumor...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Pipeline Review, H1 2018 Summary Cellular Tumor...
Catalog:
Global Markets Direct
March 2018
Price: USD 3,500.00
Tyrosine Protein Kinase Fyn - Pipeline Review, H2 2019 Summary Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Cyclin Dependent Kinase 4 - Pipeline Review, H1 2020 Summary Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11...
Catalog:
Global Markets Direct
January 2020
Price: USD 3,500.00
Cyclin Dependent Kinase 4 - Pipeline Review, H2 2019 Summary Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) Development by Therapy Areas and Indications, Stages,...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
The global Adult Malignant Glioma Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
March 2023
Price: USD 4,480.00
The global Adult Malignant Glioma Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029...
Catalog:
GIR
March 2023
Price: USD 3,480.00
Malignant gliomas, tumors derived from the neuroepithelium are collectively referred to as gliomas (gliomas), accounting for 40-50% of brain tumors,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Malignant gliomas, tumors derived from the neuroepithelium are collectively referred to as gliomas (gliomas), accounting for 40-50% of brain tumors,...
Catalog:
MRRPB5
March 2024
Price: USD 3,950.00
Glioma is a broad category of brain and spinal cord tumors that come from glial cells brain cells that support nerve cells.The symptoms, prognosis,...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Glioma is a broad category of brain and spinal cord tumors that come from glial cells brain cells that support nerve cells.The symptoms, prognosis,...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Glioma is a broad category of brain and spinal cord tumors that come from glial cells brain cells that support nerve cells.The symptoms, prognosis,...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Highlights The global Receptor Tyrosine Protein Kinase ERBB 4 market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
